Showing results (91-100 of 463) with videos related to
Sort By:
Pageof 47
Biochimica Et Biophysica Acta. Reviews on Cancer|May 1, 2021
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targetingLiz J Hernández Borrero, Wafik S El-DeiryCancer Biology & Therapy|September 26, 2003
Restoring p53-dependent tumor suppressionWenge Wang, Farzan Rastinejad, Wafik S El-DeiryPharmaceuticals (Basel, Switzerland)|November 27, 2013
Personalizing colon cancer therapeutics: targeting old and new mechanisms of actionChristina Leah B Kline, Wafik S El-DeiryCancer Biology & Therapy|December 17, 2005
Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimersArunasalam Navaraj, Toshio Mori, Wafik S El-DeiryAmerican Journal of Cancer Research|February 13, 2023
Temozolomide combined with ipilimumab plus nivolumab enhances T cell killing of MGMT-expressing, MSS colorectal cancer cellsZenovia Gonzalez, Lindsey Carlsen, Wafik S El-DeiryOncotarget|October 6, 2021
Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patientsSofia Leaf, Lindsey Carlsen, Wafik S El-DeiryBiochemical Pharmacology|May 11, 2010
Current strategies to target p53 in cancerFang Chen, Wenge Wang, Wafik S El-DeiryCancer Biology & Therapy|December 25, 2008
Non-genotoxic anti-neoplastic effects of ellipticine derivative NSC176327 in p53-deficient human colon carcinoma cells involve stimulation of p73Chao Lu, Wenge Wang, Wafik S El-DeiryCancer Research|December 25, 2002
Tissue-specific induction of p53 targets in vivoPeiwen Fei, Eric J Bernhard, Wafik S El-DeiryAdvances in Experimental Medicine and Biology|May 16, 2000
KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic deathG S Wu, K Kim, W S el-DeiryPageof 47